Lantern Pharma LTRN
NASDAQ LTRN
$0.64 -0.03 (-4.05%)
At close: Oct 19, 2026 · 4:00 PM EDT

Lantern Pharma (LTRN) Other Accumulated Expenses (2020 - 2021)

Updated

Lantern Pharma's Other Accumulated Expenses came in at $914,000 for Q3 2021, up 78.5% from the prior quarter.

Analysis

Lantern Pharma (LTRN) Other Accumulated Expenses (2020 - 2021) Analysis & Trends

At the end of FY2020, Lantern Pharma's Other Accumulated Expenses was $120,000.

  • Business Quant data shows LTRN's Other Accumulated Expenses at $512,000 (Q2 2021), $240,000 (Q1 2021) and $120,000 (Q4 2020) in the three quarters before Q3 2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,109.83 Bn 1,078.42 Bn 19.71 Bn
2 Johnson & Johnson 610.61 Bn 529.14 Bn 17.26 Bn
3 AbbVie 500.66 Bn 473.77 Bn 12.70 Bn
4 Merck 354.64 Bn 309.02 Bn 12.21 Bn
5 Novartis Ag 291.14 Bn 255.13 Bn 11.24 Bn
6 Astrazeneca 254.18 Bn 227.87 Bn 12.86 Bn
7 Amgen 229.46 Bn 184.86 Bn 7.24 Bn
8 Gilead Sciences 190.33 Bn 164.53 Bn 6.22 Bn
9 Pfizer 167.92 Bn 114.57 Bn 10.94 Bn
10 Lantern Pharma 7.95 Mn -28.21 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2021 914,000.00
Jun 30, 2021 512,000.00
Mar 31, 2021 240,000.00
Dec 31, 2020 120,000.00
Mar 31, 2020 23,000.00
API Access

Lantern Pharma Other Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=LTRN&period=max&api_key=YOUR_API_KEY